JP2022520998A5 - - Google Patents
Info
- Publication number
- JP2022520998A5 JP2022520998A5 JP2021549227A JP2021549227A JP2022520998A5 JP 2022520998 A5 JP2022520998 A5 JP 2022520998A5 JP 2021549227 A JP2021549227 A JP 2021549227A JP 2021549227 A JP2021549227 A JP 2021549227A JP 2022520998 A5 JP2022520998 A5 JP 2022520998A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- approximately
- antialbumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809475P | 2019-02-22 | 2019-02-22 | |
| US62/809,475 | 2019-02-22 | ||
| PCT/US2020/019215 WO2020172528A1 (en) | 2019-02-22 | 2020-02-21 | Albumin binding antibodies and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022520998A JP2022520998A (ja) | 2022-04-04 |
| JP2022520998A5 true JP2022520998A5 (https=) | 2023-02-28 |
Family
ID=72144485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549227A Pending JP2022520998A (ja) | 2019-02-22 | 2020-02-21 | アルブミン結合抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12479909B2 (https=) |
| EP (1) | EP3927740A4 (https=) |
| JP (1) | JP2022520998A (https=) |
| CN (1) | CN113508134B (https=) |
| TW (1) | TW202045545A (https=) |
| WO (1) | WO2020172528A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| EP3806889A4 (en) * | 2018-06-18 | 2022-07-13 | Anwita Biosciences, Inc. | CYTOKI FUSION PROTEINS AND USES THEREOF |
| TW202128961A (zh) | 2019-11-20 | 2021-08-01 | 美商安維塔生物科學股份有限公司 | 細胞激素融合蛋白及其醫藥組合物及治療應用 |
| WO2021222150A2 (en) | 2020-04-28 | 2021-11-04 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
| TW202221019A (zh) | 2020-07-30 | 2022-06-01 | 美商安維塔生物科學股份有限公司 | 介白素-22融合蛋白及其藥物組合物及治療應用 |
| EP4192959A4 (en) * | 2020-10-02 | 2024-10-30 | Agency for Science, Technology and Research | EXPRESSION SYSTEM FOR PROTEIN PRODUCTION AND SCREENING |
| EP4243938A4 (en) * | 2020-11-16 | 2025-03-05 | AB Therapeutics, Inc. | Multispecific antibodies and uses thereof |
| JP2023552462A (ja) * | 2020-12-08 | 2023-12-15 | ジャナックス セラピューティクス，インク． | 半減期延長組成物および方法 |
| TW202313685A (zh) * | 2021-06-07 | 2023-04-01 | 大陸商上海濟煜醫藥科技有限公司 | 抗人血清白蛋白的抗原結合蛋白 |
| JP2025517120A (ja) * | 2022-05-05 | 2025-06-03 | インヒブルクス バイオサイエンシズ インコーポレイテッド | アルブミン結合ポリペプチド及びその使用 |
| US20250388663A1 (en) * | 2022-08-17 | 2025-12-25 | Institut National de la Santé et de la Recherche Médicale | Improved anti-albumin nanobodies and their uses |
| WO2024051796A1 (en) * | 2022-09-09 | 2024-03-14 | Wuxi Biologics (Shanghai) Co., Ltd. | Albumin binding proteins, fusion proteins and uses thereof |
| WO2024097639A1 (en) * | 2022-10-31 | 2024-05-10 | Modernatx, Inc. | Hsa-binding antibodies and binding proteins and uses thereof |
| TW202448926A (zh) | 2023-02-17 | 2024-12-16 | 比利時商艾伯霖克斯公司 | 結合新生兒fc受體之多肽 |
| EP4713353A1 (en) * | 2023-05-17 | 2026-03-25 | Navigo Proteins | Affinity ligand for a single chain antibody fragment specific for serum albumin |
| NL2036011B1 (en) | 2023-10-12 | 2025-04-30 | Synapse Res Institute | Molecules for reversing anti-coagulant activity of direct oral anticoagulants |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1558645B1 (en) | 2002-11-08 | 2011-07-27 | Ablynx N.V. | Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation |
| EP2102244A2 (en) | 2006-12-19 | 2009-09-23 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| EP2692736B1 (en) | 2008-10-14 | 2018-04-18 | National Research Council Of Canada | Bsa-specific antibodies |
| WO2011006915A2 (en) * | 2009-07-16 | 2011-01-20 | Glaxo Group Limited | Improved anti-serum albumin binding single variable domains |
| US9556273B2 (en) * | 2010-03-29 | 2017-01-31 | Vib Vzw | Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages |
| WO2012022703A2 (en) | 2010-08-20 | 2012-02-23 | Glaxo Group Limited | Improved anti-serum albumin binding variants |
| US9670275B2 (en) * | 2012-01-23 | 2017-06-06 | Ablynx N.V. | Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumors |
| JP6256882B2 (ja) * | 2012-02-15 | 2018-01-10 | アムニクス オペレーティング インコーポレイテッド | 第ｖｉｉｉ因子組成物、ならびに組成物の作製方法および用途 |
| WO2016034968A1 (en) | 2014-09-02 | 2016-03-10 | Pfizer Inc. | Therapeutic antibody |
| JP6859259B2 (ja) | 2014-11-19 | 2021-04-14 | ジェネンテック， インコーポレイテッド | ＢＡＣＥｌに対する抗体及び神経疾患免疫療法のためのその使用 |
| US9708412B2 (en) * | 2015-05-21 | 2017-07-18 | Harpoon Therapeutics, Inc. | Trispecific binding proteins and methods of use |
| LT3374392T (lt) | 2015-11-13 | 2022-01-25 | Ablynx Nv | Patobulinti serumo albuminą surišantys imunoglobulino kintami domenai |
| EP3493844A4 (en) * | 2016-05-20 | 2021-03-24 | Harpoon Therapeutics Inc. | SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN |
| RU2022101604A (ru) * | 2016-12-07 | 2022-03-29 | Аблинкс Нв | Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином |
| EP3621994A4 (en) | 2017-05-12 | 2020-12-30 | Harpoon Therapeutics, Inc. | MESOTHELIN BINDING PROTEINS |
| EP4029877B1 (en) * | 2017-08-03 | 2024-01-17 | Amgen Inc. | Interleukin-21 muteins and methods of treatment |
| CA3076250A1 (en) * | 2017-10-02 | 2019-04-11 | Vib Vzw | Compounds to inhibit bacterial s-layer protein assembly |
| EP3806889A4 (en) | 2018-06-18 | 2022-07-13 | Anwita Biosciences, Inc. | CYTOKI FUSION PROTEINS AND USES THEREOF |
| TW202128961A (zh) * | 2019-11-20 | 2021-08-01 | 美商安維塔生物科學股份有限公司 | 細胞激素融合蛋白及其醫藥組合物及治療應用 |
| TW202221019A (zh) * | 2020-07-30 | 2022-06-01 | 美商安維塔生物科學股份有限公司 | 介白素-22融合蛋白及其藥物組合物及治療應用 |
-
2020
- 2020-02-21 CN CN202080015296.8A patent/CN113508134B/zh active Active
- 2020-02-21 WO PCT/US2020/019215 patent/WO2020172528A1/en not_active Ceased
- 2020-02-21 TW TW109105677A patent/TW202045545A/zh unknown
- 2020-02-21 US US17/432,488 patent/US12479909B2/en active Active
- 2020-02-21 JP JP2021549227A patent/JP2022520998A/ja active Pending
- 2020-02-21 EP EP20759885.5A patent/EP3927740A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022520998A5 (https=) | ||
| US20230211006A1 (en) | Cysteine linked nanobody dimers | |
| AU2021290305B2 (en) | Nanobody dimers linked via C-terminally engineered cysteins | |
| KR101782487B1 (ko) | 신규 항-메소텔린 항체 및 이를 포함하는 조성물 | |
| JP2016509014A (ja) | 新規の多特異的構成物 | |
| US20160009824A1 (en) | Tetravalent bispecific antibodies | |
| CA3089653A1 (en) | Anti-claudin 18.2 antibodies and uses thereof | |
| CN114341186A (zh) | 双特异性抗LRRC15和CD3ε抗体 | |
| JP2013502913A5 (https=) | ||
| JP2013532968A5 (https=) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2012519492A5 (https=) | ||
| JP2021518761A5 (https=) | ||
| CN115461373A (zh) | 密蛋白18.2的抗体及其用途 | |
| CN114786720A (zh) | TriAx抗体的组合物及其制备和使用方法 | |
| KR20240135654A (ko) | 항-her2/trop2 항체 및 이의 용도 | |
| JP2022502079A5 (https=) | ||
| US20250019457A1 (en) | Trop2 antibodies | |
| KR20250012612A (ko) | 고형 종양을 치료하는 방법 | |
| US20250136694A1 (en) | Anti-b7-h4 antibody, and preparation method therefor and use thereof | |
| WO2025021953A1 (en) | Antigen-binding molecules capable of binding interferon gamma | |
| WO2025117872A1 (en) | Bispecific antibody-like protein and methods of making and using thereof | |
| WO2026060187A1 (en) | Multispecific antibody-drug conjugates (adc) targeting cdh17-expressing tumors and method of making and using thereof | |
| HK40104915A (zh) | 靶向表达cdh17的肿瘤的多特异性抗体及其制备和使用方法 | |
| WO2025117871A1 (en) | Bispecific tetravalent antibody targeting her2 and her3 |